Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Veru Inc (VERU) advances its biopharmaceutical pipeline with promising clinical results while navigating financial hurdles ...

The Washington Commanders have difficult offseason roster decisions, and here's one surprise cut candidate for 2025.

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Arizona focuses its draft efforts on position players and the results are evident in their strong group of hitters as top ...

The Dodgers' system is down a little, but it is still outstanding overall, with several high-upside talents who could develop ...

Cisco's next quarterly call, which will reflect our fiscal year 2025 third-quarter results, will be on Wednesday, May 14, ...

Cold weather got you feeling cooped up? The 2025 Newport Winter Festival is the perfect excuse to get out and have fun this ...

Star Trek: Section 31 has been on many minds since its release at the end of January 2025. There have been discussions, ...

Cisco Systems, Inc. ( NASDAQ: CSCO) Q2 2025 Earnings Conference Call February 12, 2025 4:30 PM ET Sami Badri - Head, Investor Relations Chuck Robbins - Chair and Chief Executive Officer Scott Herren - ...

Sally Beauty Holdings, Inc. ( NYSE: SBH) Q1 2025 Earnings Conference Call February 13, 2025 8:30 AM ET Jeff Harkins - VP, IR and Treasurer Denise Paulonis - President and CEO Marlo Cormier - CFO ...